RxC International
  • About Us
    • RxC Differentiation
    • RxC Team
    • RxC Clients
    • Press Releases
    • Contact Us
    • Careers
  • Consulting
    • Corporate Strategy
    • New Product Strategy
    • Commercial Excellence
    • Value Chain Optimization
    • US Entry Strategy
  • Publications
    • Dev & Commercialization Series
    • Investment Series
  • Advisory
    • Product Dev & Commercialization
    • Value Chain Management
    • Investing into BioPharma
  • Insights
    • Key BioPharma Drivers
    • Types of Drug Design
    • Evidence-Based vs. Value-Based
    • Product Pricing Strategy
    • Product Manufacturing
    • Payer Decisions
    • Patient Protection
    • Product Life Cycle Management
    • BioPharma Business Models
    • Investment Framework
    • Common Investment Transactions

Corporate Strategy

 

New Product Strategy

 

Commercial Excellence

                                 

 

"RxC International is a premier life sciences management consulting firm."
 
The firm collaborates with life sciences companies to identify and develop growth opportunities.  RxC has deep expertise in corporate strategy, new product planning and commercial excellence.  RxC clients include leading pharmaceutical, biotechnology, and medical technology companies around the world.  We also support private equity and venture capital firms on strategic transactions.  Our offices are located in New Jersey, Massachusetts, and California.


Terms of Use  |  Privacy Policy  |  Sitemap
Powered by Readyportal  Copyright 2016 RxC International LLC. All rights reserved.
  • RxC Differentiation
  • RxC Team
  • RxC Clients
  • Press Releases
    • CBP news
    • Value Chain Management
    • Investing into BioPharma Products
    • BioPharma Primer
    • Rich Tinsley Joins
    • Rich Presents at PBIRG
  • Contact Us
  • Careers
  • Corporate Strategy
  • New Product Strategy
    • Product Dev & Commercialization
    • Product Dev & Commercialization
  • Commercial Excellence
  • Value Chain Optimization
  • US Entry Strategy
  • Dev & Commercialization Series
    • Commercialization of BioPharma Products
    • BioPharma Value Chain Management
    • BioPharma Primer
  • Investment Series
    • Investing
  • Product Dev & Commercialization
  • Value Chain Management
  • Investing into BioPharma
  • Key BioPharma Drivers
  • Types of Drug Design
  • Evidence-Based vs. Value-Based
  • Product Pricing Strategy
  • Product Manufacturing
  • Payer Decisions
  • Patient Protection
  • Product Life Cycle Management
  • BioPharma Business Models
  • Investment Framework
  • Common Investment Transactions